Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19372304rdf:typepubmed:Citationlld:pubmed
pubmed-article:19372304lifeskim:mentionsumls-concept:C0039005lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C1708096lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:19372304lifeskim:mentionsumls-concept:C2352099lld:lifeskim
pubmed-article:19372304pubmed:issue6lld:pubmed
pubmed-article:19372304pubmed:dateCreated2009-5-27lld:pubmed
pubmed-article:19372304pubmed:abstractTextMyocardial ischemia-reperfusion (IR) injury occurs frequently in the setting of hypercholesterolemia. We investigated the potential efficacy of a novel thrombin fragment (TP508) on IR injury in a hypercholesterolemic porcine model. Twenty-one hypercholesterolemic male Yucatan pigs underwent 60 min of mid-left anterior descending coronary artery occlusion followed by 120 min of reperfusion. Pigs received either placebo (control, n = 7) or TP508 in two doses (TP508 low dose, n = 7, as bolus of 0.5 mg/kg 50 min into ischemia and an infusion of 1.25 mg.kg(-1).h(-1) during reperfusion period or TP508 high dose, n = 7, a double dose of TP508 low-dose group). Myocardial function was monitored throughout the experiment. The area at risk and myocardial necrosis were determined by Monastryl blue/triphenyl tetrazolium chloride staining. Apoptosis in the ischemic territory was assessed. Coronary microvascular reactivity to endothelium-dependent and -independent factors was measured. Myocardial necrosis was lower in both TP508-treated groups vs. control (P < 0.05). Regional left ventricular function was improved only in the TP508 high-dose group (P < 0.05). Endothelium-dependent coronary microvascular reactivity was greater in both TP508-treated groups (P < 0.05) vs. control. The expression of proteins favoring cell survival, 90-kDa heat shock protein and phospho-Bad (Ser112) was higher in the TP508 high-dose group (P < 0.05). The expression of the cell death signaling proteins, cleaved caspase-3 (P < 0.05), apoptosis-inducing factor (P < 0.05), and poly-ADP ribose polymerase (P = 0.07) was lower in the TP508 low-dose group vs. TP508 high-dose and control. The terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cell count was lower in both TP508 groups compared with the control (P < 0.05). This study demonstrates that, in hypercholesterolemic pigs, TP508 decreases myocardial necrosis and apoptosis after IR. Thus TP508 may offer a novel approach in protecting the myocardium from IR injury.lld:pubmed
pubmed-article:19372304pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:languageenglld:pubmed
pubmed-article:19372304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:citationSubsetIMlld:pubmed
pubmed-article:19372304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19372304pubmed:statusMEDLINElld:pubmed
pubmed-article:19372304pubmed:monthJunlld:pubmed
pubmed-article:19372304pubmed:issn8750-7587lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:ClementsRicha...lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:BianchiCesari...lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:SellkeFrank...lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:WagstaffJohnJlld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:FengJunJlld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:LiuYuhongYlld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:OsipovRobert...lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:RobichMichael...lld:pubmed
pubmed-article:19372304pubmed:authorpubmed-author:GlazerHilary...lld:pubmed
pubmed-article:19372304pubmed:issnTypePrintlld:pubmed
pubmed-article:19372304pubmed:volume106lld:pubmed
pubmed-article:19372304pubmed:ownerNLMlld:pubmed
pubmed-article:19372304pubmed:authorsCompleteYlld:pubmed
pubmed-article:19372304pubmed:pagination1993-2001lld:pubmed
pubmed-article:19372304pubmed:dateRevised2010-9-27lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
pubmed-article:19372304pubmed:meshHeadingpubmed-meshheading:19372304...lld:pubmed
More...